Evolutionary Genomics, Inc.
FNAM
Rank in Stocks
#34912
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the... Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$1.33K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Evolutionary Genomics, Inc. (FNAM)
Category
Healthcare
EPS for Evolutionary Genomics, Inc. (FNAM)
EPS as of December 2022 TTM: $-0.29
According to Evolutionary Genomics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.29. At the end of 2022 the company had an EPS of $-0.35, an increase over its 2021 EPS of $-0.52.
EPS history for Evolutionary Genomics, Inc. from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.29 | -17.14% |
| 2022 | $-0.35 | -32.69% |
| 2021 | $-0.52 | 52.94% |
| 2020 | $-0.34 | 161.54% |
| 2019 | $-0.13 | -31.58% |
| 2018 | $-0.19 | 107.20% |
| 2017 | $-0.09 | -54.15% |
| 2016 | $-0.20 | 243.05% |
| 2015 | $-0.06 | -72.24% |
| 2014 | $-0.21 | 40.00% |
| 2013 | $-0.15 | 15.38% |
| 2012 | $-0.13 | 0.00% |
| 2011 | $-0.13 | -27.78% |
| 2010 | $-0.18 | 28.57% |
| 2009 | $-0.14 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -5,500.00% |
US
|
|
| $-7.07 | 2,337.93% |
US
|
|
| $-5.29 | 1,724.14% |
AU
|
|
| $12.88 | -4,541.41% |
BE
|
|
| $21.56 | -7,534.48% |
NL
|
Questions about Evolutionary Genomics, Inc.'s earnings per share (EPS)
What is Evolutionary Genomics, Inc.'s earnings per share (EPS)?
Evolutionary Genomics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.29, as of Dec 2022.
What was Evolutionary Genomics, Inc.'s earnings per share (EPS) in 2022?
In 2022, Evolutionary Genomics, Inc.'s earnings per share (EPS) was $-0.35, compared with $-0.52 in 2021.
How has Evolutionary Genomics, Inc.'s earnings per share (EPS) changed since 2017?
From 2017 to 2022, Evolutionary Genomics, Inc.'s earnings per share (EPS) was highest in 2017 ($-0.09) and lowest in 2021 ($-0.52).
How does Evolutionary Genomics, Inc.'s earnings per share (EPS) compare with similar companies?
Evolutionary Genomics, Inc.'s earnings per share (EPS) ($-0.29) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.